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Addictive drugs have in common that they target the mesocorticolimbic dopamine (DA) system. This system
originates in the ventral tegmental area (VTA) and projects mainly to the nucleus accumbens (NAc) and
prefrontal cortex (PFC). Here, we review the effects that such drugs leave on glutamatergic and
GABAergic synaptic transmission in these three brain areas. We refer to these changes as drug-evoked
synaptic plasticity, which outlasts the presence of the drug in the brain and contributes to the reorganization
of neural circuits.While inmost cases these early changes are not sufficient to induce the disease, with repet-
itive drug exposure, they may add up and contribute to addictive behavior.From Acute Drug Effects to Persistent Synaptic
Adaptations
Addictive drugs mediate their reinforcing properties by targeting
the mesocorticolimbic dopamine (DA) system, which we define
as including the ventral tegmental area (VTA) and its major
targets, the nucleus accumbens (NAc) and prefrontal cortex
(PFC). Despite their chemical diversity and individual molecular
targets, all addictive drugs have in common that they increase
DA concentrations in projection areas of the VTA as well as the
VTA itself (Di Chiara and Imperato, 1988; Nestler, 2005). In brief
(for a more extensive review on the pharmacology of addictive
drugs, see the review by D. Sulzer in the present issue of Neuron
and Lu¨scher and Ungless, 2006), nicotine can directly increase
firing of DA neurons through a4b2-containing nicotinic receptors
that are expressed on DA neurons (Maskos et al., 2005). Opioids
(Johnson and North, 1992), cannabinoids (Szabo et al., 2002),
the club drug g-hydroxybutyrate (GHB) (Cruz et al., 2004), and
benzodiazepines (Tan et al., 2010) primarily target GABAergic
interneurons in the VTA and decrease their activity, which leads
to an indirect increase of DA neuron activity. Such disinhibition
can occur because of the cell-type-specific expression of the
respective receptors (e.g., m-opioid receptors are expressed
on GABA, but not on DA neurons) or because GABA neurons
are more sensitive to the drug than DA neurons. Benzodiaze-
pines, for example, primarily silence interneurons because
unitary GABA-A receptor-mediated currents in these cells are
larger than in DA neurons. This observation correlates with the
interneuron-specific expression of the a1 receptor subunit iso-
form (Tan et al., 2010). Finally, the psychostimulants cocaine,
amphetamines, and ecstasy target the DA transporter (DAT),
which is normally responsible for the reuptake of DA (Sulzer
et al., 2005). Since midbrain DA neurons also release DA from
their dendrites (Cheramy et al., 1981; Beckstead et al., 2004),
DAT inhibition causes an increase of DA in the VTA as well as
in the NAc and PFC. Important mechanistic differences exist650 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.between the individual members of this class. Cocaine directly
inhibits the DAT, while amphetamines are transporter substrates
that are taken up into the cell to enhance nonvesicular release of
DA. Psychostimulants have in common that they decrease the
firing rate of DA neurons through D2 receptor-mediated autoin-
hibition (Groves et al., 1975; Chen and Reith, 1994). The Gi/o-
coupled D2 receptors hyperpolarize DA neurons by activating
GIRK/Kir3 channels. Because the block of DA reuptake exceeds
the consequences of reducing DA cell firing frequency, there is
nevertheless a net increase of ambient DA.
Addiction is normally defined as the compulsive use of a drug
despite the negative consequences. An addictive drug has the
potential to induce the disease, but does so only in a fraction
of consumers. Here, we focus on the initial adaptive changes
required, but not sufficient, to cause addiction (Redish et al.,
2008). These initial actions of addictive drugs have been exten-
sively studied and remain important targets for possible thera-
peutic interventions in the treatment of addiction (Figure 1). For
example, the drug varenicline, which is used in the treatment
of nicotine addiction, targets nicotinic receptors on VTA DA
neurons (Coe et al., 2005). However, the acute actions of drugs
of abuse dissipate as the drug leaves the brain and therefore,
alone, cannot explain the development of addictive behaviors.
To understand addiction, we must elucidate the specific traces
the drug experience leaves in the brain and which of these are
causally related to the development of addiction. Here, we will
focus on some of the key synaptic adaptations that occur after
single or repetitive exposures to an addictive drug. This focus
is based on the assumption that, like virtually all forms of adap-
tive experience-dependent plasticity, the neural circuit adapta-
tions that underlie drug-induced behavioral changes will involve
drug-induced synaptic changes. Indeed, converging evidence
from many studies suggests that addictive drugs modify
synaptic transmission in the mesocorticolimbic DA system by hi-
jacking mechanisms normally used for adaptive forms of
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Figure 1. The Mesocorticolimbic
Dopamine System as Target of Addictive
Drugs
On a sagittal slice, the ventral tegmental area
(VTA), the nucleus accumbens (NAc), and the
prefrontal cortex (PFC) can be visualized. The
projection neurons are mostly dopaminergic and
under inhibitory control of local GABA neurons
(i.e., interneurons). Enlarged schematics are
shown to illustrate three cellular mechanisms by
which addictive drugs increase mesolimbic DA
levels. Nicotine can directly depolarize DA
neurons, while opioids, GHB, benzodiazepines,
and cannabinoids act indirectly via pre- and post-
synaptic inhibition of interneurons (i.e., disinhibi-
tion). Cocaine, amphetamines, and ecstasy target
the dopamine transporter (DAT) on axon terminals
as well as on dendrites of DA neurons. While
cocaine acts as an inhibitor of the DAT, amphet-
amines and ecstasy promote nonvesicular
release. In both cases, DA levels in the VTA,
NAc, and PFC increase.
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Reviewexperience-dependent synaptic plasticity; hence the term
‘‘drug-evoked synaptic plasticity.’’ However, the term should
not imply that drug exposure alone is necessarily sufficient
to elicit synaptic plasticity. On the contrary, many forms of
drug-evoked synaptic plasticity appear to depend on the context
in which the drug has been experienced, presumably because
the final synaptic adaptation will depend both on the molecular
action of the drug and the pattern of neural activity in the
brain at the time the drug is experienced. It is also important
to note that a single drug experience is certainly not sufficient
to induce addiction. However, the synaptic and neural circuit
adaptations caused by a drug experience often persist and lay
the foundation upon which further drug-induced adaptations
occur.
Focusing on the mesocorticolimbic DA system makes sense
not only because it is well established to be a major site of action
of addictive drugs, but also because it has long been considered
a structure that is essential for translating motivations into goal-
directed actions (Phillips et al., 2003; Zweifel et al., 2009). The
synaptic adaptations within this system that occur in response
to addictive drugs and how these may contribute to addiction-
related behaviors in rodent models have been the subject of
a number of recent reviews (Kauer and Malenka, 2007; Thomas
et al., 2008; Russo et al., 2010; Kalivas et al., 2009; Schmidt and
Pierce, 2010; Wolf and Ferrario, 2010; Bowers et al., 2010).
Rather than comprehensively reviewing this same material, we
will instead highlight some of the most salient findings with an
emphasis on the most recent results that point to important
avenues of future research. We will also exhibit the strong bias
that changes in synaptic function can best be assayed using
electrophysiological techniques. Biochemical and imaging-
based measurements certainly provide important information
that is critical for understanding the mechanisms underlying
the synaptic and circuit adaptations caused by drugs of abuse.
However, by definition, changes in synaptic function can be
unequivocally provided only by directly measuring function,and this requires recording the postsynaptic responses to
afferent stimulation.
Molecular Mechanisms of Drug-Evoked Plasticity
VTA
Excitatory Transmission. In the 1990s, based primarily on
pharmacological manipulations and biochemical assays, as
well as the excitement generated by the elucidation of some of
the mechanisms and putative function of hippocampal LTP
and LTD, it was proposed that modifications of excitatory
synaptic transmission in the mesolimbic DA system are impor-
tant for the neural circuit adaptations underlying some of the
long-lasting behavioral consequences of administration of drugs
of abuse, particularly psychostimulants (Overton et al., 1999;
Wolf, 1998; Kalivas, 1995). A direct test of this hypothesis was
subsequently performed and resulted in the first characterization
of a form of drug-evoked synaptic plasticity (Ungless et al.,
2001). The experimental approach, now standard, involved
preparing acute midbrain slices from an animal that 24 hr earlier
had received a single noncontingent injection of cocaine (or
saline) and recording from VTA DA neurons. As a surrogate
measure of synaptic strength, the authors measured the ratio
of the AMPA receptor-mediated ESPC (AMPAR-EPSC) to the
NMDA receptor-mediated EPSC (NMDAR-EPSC); the so-called
AMPAR/NMDAR ratio. This ratio was significantly increased for
approximately a week following the injection of cocaine, and
several electrophysiological measures suggested that it was
caused, at least in part, by an increase in the AMPAR-EPSCs.
A recent study re-examined this question by measuring unitary
synaptic responses evoked by a highly localized glutamate
source (two-photon photolysis of caged glutamate [Mameli
et al., 2011]). The study concludes that both AMPAR transmis-
sion and NMDAR transmission are altered. A population of
synapses shows strong rectification of the AMPAR-EPSC along
with a decrease of the amplitude of the NMDAR-EPSC. Consis-
tent with this conclusion, the magnitude of LTP at theseNeuron 69, February 24, 2011 ª2011 Elsevier Inc. 651
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2001). This transient enhancement of excitatory synaptic
strength in VTA DA cells also occurs following administration of
other addictive drugs, including morphine, nicotine, ethanol,
and benzodiazepines, but not with nonaddictive psychoactive
substances such as fluoxetine or carbamazepine (Saal et al.,
2003). (The case, however, seemsmore complicated for ethanol.
When comparing two mouse strains, one injection of ethanol did
not affect the AMPAR/NMDAR ratio in C57BL/6 and led to
a decrease in DAB mice [Wanat et al., 2009]. The authors
propose that in DAB, a decreased NMDAR signaling is at the
origin of this adaptation.) Furthermore, prolonged self-adminis-
tration of cocaine, unlike passive injections of cocaine or self-
administration of food or sucrose, elicits an increase in the
AMPAR/NMDAR ratio lasting 3 months (Chen et al., 2008).
Cues predicting reward also caused this increase, suggesting
that this modification of excitatory synaptic function on VTA
DA neurons has important roles in shaping behavioral adapta-
tions (Stuber et al., 2008).
Several results suggest that activation of VTA DA neurons
alone is sufficient to elicit this form of drug-evoked synaptic plas-
ticity when paired with spontaneous activity. Applying cocaine to
isolated midbrain slices caused an increase in the AMPAR/
NMDAR ratio in DA cells when measured several hours later
(Argilli et al., 2008). In vivo, driving burst firing in DA cells using
light activation of channelrhodopsin (ChR2) also caused synaptic
adaptations in DA cells when measured 24 hr later (Brown et al.,
2010). The synaptic plasticity induced by both of these manipu-
lations was prevented by pharmacological blockade of D1/D5
receptors in the VTA, suggesting that an increase in DA within
the VTA is a critical trigger (Schilstro¨m et al., 2006). Consistent
with this conclusion is the finding that this plasticity is not elicited
in mice expressing a mutated DAT that is insensitive to cocaine
(Brown et al., 2010). An additional induction requirement for this
drug-evoked synaptic plasticity is activation of NMDARs on the
DA neurons. This conclusion is based on the observations that
systemic administration of an NMDAR antagonist blocks the
plasticity (Ungless et al., 2001), as does ablation of the critical
NMDAR subunit NR1 selectively in DA neurons (Engblom et al.,
2008; Zweifel et al., 2008). A simple model that can explain all
of these results is that DA receptor activation on VTA DA neurons
leads to an increase in NMDAR EPSCs and that this in turn facil-
itates the generation of NMDAR-dependent LTP (Schilstro¨m
et al., 2006).
The expression mechanisms of the drug-evoked plasticity at
excitatory synapses on VTA DA neurons have also been
explored. Because the original report of a cocaine-induced
increase in the AMPAR/NMDAR ratio suggested that this was
due to an upregulation of AMPARs, it was surprising to find
that in mice treated with cocaine, the AMPAR-EPSCs exhibited
a partial inward rectification (Bellone and Lu¨scher, 2006), which
is a hallmark of GluA2-lacking AMPARs (Isaac et al., 2007; Liu
and Zukin, 2007). The presence of such AMPARs was confirmed
by the sensitivity of the EPSCs to external polyamine toxins such
as Joro spider toxin as well as an increased single-channel
conductance estimated using nonstationary fluctuation analysis
(Mameli et al., 2007). While immunohistochemical staining with
light microscopic resolution failed to reveal changes in AMPAR652 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.subunit expression (Lu et al., 2002), immunogold labeling at
the electron microscopy level did show an increase of GluA1
after morphine treatment (Lane et al., 2008) and that cocaine
treatment causes a decrease of GluA2 content at synapses
(Mameli et al., 2007; Brown et al., 2010). These results are
consistent with a scenario whereby GluA2-containing receptors
are exchanged for GluA2-lacking ones and no significant
increase in the number of synaptic AMPARs occurs. The inser-
tion of GluA2-lacking AMPARs that are highly conductive at
negative potentials but carry minimal current at positive poten-
tials can explain an increase of the AMPAR/NMDAR ratio when
calculated at 70 mV/+40 mV, but not when both components
are measured at +40 mV. This raises the possibility that cocaine
administration may also decrease the number and/or function of
synaptic NMDARs, which is supported by the recent observation
of a decrease in unitary NMDAR-EPSCs following cocaine treat-
ment (Mameli et al., 2011). This study also examined the func-
tional consequences for further activity-dependent synaptic
plasticity. While in slices an induction protocol that depolarizes
DA neurons led to LTP, thus obeying a Hebbian induction rule,
this protocol was inefficient after cocaine treatment. Conversely,
a slight hyperpolarization of the DA neurons during afferent stim-
ulation (i.e., ‘‘anti-Hebbian’’ coincidence) induced a strength-
ening of AMPAR transmission only in slices from mice that had
received cocaine. Thus, cocaine administration not only causes
a lasting change in the basal properties of excitatory synapses
but may also inverse the rules that govern the induction of
activity-dependent synaptic plasticity.
As mentioned above, drug-evoked synaptic plasticity at this
synapsepersists for about aweek after a single injection. Beyond
this time, the receptor redistribution is reversed and the initial
state of the synapse restored (Figure 2). Several lines of evidence
implicatemetabotropicmGluR1 receptors in this reversal. In fact,
pharmacological or synaptic activation of mGluR1 in slices from
cocaine-treated mice quickly removes GluA2-lacking AMPARs
and replaces them with GluA2-containing ones, leading to an
overall depression of synaptic transmission (Bellone and
Lu¨scher, 2005, 2006). Such mGluR-LTD relies on mammalian
target of rapamycin (mTOR) signaling and rapid synthesis of
GluA2 subunits via local translation from prefabricated mRNA
present in dendrites of DA neurons (Mameli et al., 2007). More-
over, interfering with mGluR1 function in vivo by introducing
a TAT-conjugated, dominant-negative peptide that disrupts
mGluR1-Homer interaction selectively in the VTA significantly
prolongs the persistence of cocaine-evoked plasticity (Mameli
et al., 2009). Taken together, these results suggest that mGluR1
triggers an endogenous defense mechanism that ensures the
removal of calcium-permeable AMPARs, which were inserted
in response to drug exposure. It will be important to determine
why such a mechanism does not appear to function following
prolonged self-administration of cocaine (Chen et al., 2008).
Although the drug-evoked synaptic plasticity in VTA DA
neurons is robust, recent studies have demonstrated that these
cells are not homogeneous but instead exhibit different electro-
physiological and molecular properties depending on the
specific brain area to which they project (Lammel et al., 2008;
Margolis et al., 2006). This distinction between different
subtypes of VTA DA neurons may be important because the
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Figure 2. Drug-Evoked Synaptic Plasticity
in Excitatory Synapses onto VTA DA
Neurons
The schematics are drawn from a postembedding
EM micrograph of a drug-naive mouse (courtesy
of Rafael Lujan, Albacete, Spain). Note that these
asymmetrical synapses are made directly onto
the shaft of the dendrite (aspiny shaft synapse). In
naive animals, NMDARs and AMPARs are present,
the latter all containing GluA2. After one dose of
cocaine, some GluA2-containing AMPARs are
exchanged for GluA2-lacking ones through mech-
anisms involving endo- and exocytosis. At the
same time NMDAR function decreases. After
a week of a passive injection (months after self-
administration), the baseline composition is
restored through mGluR1 activation, mTOR
signaling, anddenovosynthesisofGluA2 frompre-
fabricated mRNA. Throughout the whole process,
the total number of AMPARs remains constant.
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a feature to identify DA neurons, yet, for example, VTA DA
neurons projecting to the medial PFC and the amygdala lack Ih
currents and also express low levels of DAT and D2 receptors.
Indeed, recent work has found that these mesocortical DA
neurons do not exhibit an increase in the AMPAR/NMDAR ratio
following single or chronic administration of cocaine, but do
express an increase following a salient but aversive stimulus
(Lammel and Malenka, 2010). The exclusively DAergic nature of
VTAprojection neurons has also beenquestioned. Using optoge-
netic tools, unambiguous functional evidence for corelease of DA
and glutamate from VTA projection neurons has been provided
(Tecuapetla et al., 2010; Stuber et al., 2010). In addition, pure glu-
tamatergic and GABAergic projection neurons also exist in the
VTA (Yamaguchi et al., 2007; Margolis et al., 2008). Whether the
activity of the latter is affected by addictive drugs and how core-
lease of glutamate affects drug action are largely unknown.
An additional important question is whether the drug-evoked
synaptic plasticity in VTA DA neurons is induced uniformly at
all excitatory inputs onto a given DA neuron. These arise from
many origins, including the PFC, the amygdala, the lateral hypo-
thalamus, and brain stem nuclei such as the pedunculopontine
tegmentum and the basal nucleus of the stria terminalis. Optoge-
netic approaches involving expression of ChR2 in specific brain
regions should help provide an answer to this question in the
near future. Identifying both the specific synapses that are
subject to drug-evoked plasticity and how the sites to which
DA cells project influence their synaptic adaptations will beNeuron 69,a necessary prerequisite to fully under-
standing the complex neural circuit adap-
tations caused by drug experiences.
Orexin and CRF Modulation of Drug-
Evoked Synaptic Plasticity. Both cortico-
tropin releasing factor (CRF) and orexin
A/hypocretin-1 (oxA/hcrt-1) can modulate
drug-evoked synaptic plasticity, presum-
ably through their effect on firing rates of
VTA DA neurons and potentiation of
NMDAR-mediated synaptic transmission(for a recent review, see Borgland et al., 2010). While either
neuropeptide, when administered in the VTA, can lead to DA
release in target regions of the VTA, distinct subpopulations of
DA neurons seem to be the target for these substances. Cells
that synthesize orexin are located in lateral hypothalamus and
project to VTA DA neurons, where they release oxA/hcrt-1 and
oxB/hcrt-2. DA neurons in turn express both orexin 1 and orexin
2 receptors and are generally excited by their activation. It has
been suggested that orexin preferentially activates caudomedial
VTA neurons that primarily project to the PFC and NAc shell (Vit-
toz et al., 2008) and that this effect contributes to the behaviors
elicited by drugs of abuse as well as natural rewards. Indeed, the
increase in the AMPAR/NMDAR ratio following in vivo cocaine
administration was blocked when an OXR1 antagonist was
administered systemically before the cocaine injection (Borgland
et al., 2006).
CRF neurons projecting to the VTA are found in the limbic fore-
brain and the paraventricular nucleus of the hypothalamus
(Rodaros et al., 2007). About one-quarter of VTA DA neurons,
mostly located in the parabrachial pigmented (PBP) region of
the VTA, express both CRF-R2 and the CRF binding protein
(CRF-BP). These are both required for a slowly developing, tran-
sient potentiation of NMDAR-mediated synaptic transmission eli-
cited by application of CRF (Ungless et al., 2003). Whether, like
oxA/hcrt-1, CRF is important for drug-evoked synaptic plasticity
inVTADAneuronshasnotbeen investigated.Furthermore,genet-
ically modified mice have not been used thus far to study the role
of these peptide systems in drug-evoked synaptic plasticity.February 24, 2011 ª2011 Elsevier Inc. 653
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synapses are capable of expressing a form of potentiation called
LTP(GABA), which is modulated by addictive drugs (Nugent
et al., 2007). NMDAR activation by a train of high-frequency stim-
ulation causes a rise in intracellular calcium, which triggers the
release of nitric oxide (NO). NO then acts as a retrograde
messenger to activate guanylate cyclase, eventually increasing
release from GABAergic terminals. In vivo exposure to morphine
prevents LTP(GABA) via interruption of NO to guanylate cyclase
signaling (Nugent et al., 2007, 2009). This inhibition of LTP
(GABA) can also be observed following cocaine and nicotine
administration, albeit with a distinct time course for each of the
drugs tested (Niehaus et al., 2010). Inhibition by morphine can
be observed within a couple of hours and lasts approximately
5 days. The effects of nicotine wear off more quickly, within
24 hr, while the cocaine-mediated inhibition needs more time
to be fully established. Ethanol also blocks LTP(GABA), an effect
that is reversed by naloxone, a m-opioid receptor (MOR) antago-
nist (Guan and Ye, 2010), suggesting that ethanol may exert its
block via the opioid system. To understand the consequences
of LTP(GABA) inhibition on mesolimbic DA circuitry, it will be
important to determine the precise connectivity of GABAergic
neurons and which specific inputs are being modulated. VTA
DA neurons receive inhibitory input from medium spiny neurons
(MSNs) of the NAc and the rostromedial tegmental nucleus
(RMTg) as well as from interneurons within the VTA, which them-
selves receive projections form the NAc.
Chronic drug exposure leads to adaptive changes of inhibi-
tory transmission onto VTA DA neurons (Liu et al., 2005). After
several daily injections of cocaine, baseline inhibitory transmis-
sion becomes depressed. The induction requirements of this
plasticity remain largely unknown, but appear to involve
priming by BDNF (Pu et al., 2006). Its expression relies on
a redistribution of GABA-ARs in the postsynaptic membrane.
The major consequence of this downregulation of GABAergic
transmission has been proposed to be a lower threshold for
the induction of subsequent spike-timing-dependent LTP at
glutamatergic synapses (Liu et al., 2005). However, other
groups have found that this form of LTP is reduced following
cocaine administration (Luu and Malenka, 2008; Argilli et al.,
2008). Once again, to understand the circuit repercussions of
these drug-evoked synaptic adaptations, it will be crucial to
determine which specific projections are modified: the one
directly arising from the NAc, the RMTg, or local inputs from
interneurons.
Nucleus Accumbens
Over 95% of the cells within the NAc are MSNs, which receive
excitatory inputs from four major brain regions: the PFC, the
ventral subiculum of the hippocampus, the basolateral amyg-
dala, and the thalamus (Sesack and Grace, 2010). Surprisingly,
little is known about potential differences in the synaptic proper-
ties of these different inputs and whether these different
synapses are modified in an identical fashion by drugs of abuse
during the transition to addiction. This is an important topic,
given that these different inputs must serve different behavioral
functions. Another critical feature of NAc MSNs is that as in the
dorsal striatum, they can be divided into two major classes,
direct pathway and indirect pathway MSNs, with the former654 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.primarily expressing D1 DA receptors and the latter D2 DA
receptors (Kreitzer andMalenka, 2008). Finally, the NAc contains
two subregions known as the core and the shell, which differ in
their anatomical connectivity and their presumptive functions.
The complexity of NAc circuitry generated by its multiple
different inputs, different cell types, and different subregions
provides a major challenge for understanding the neural circuit
modifications that underlie the transition to addiction. Neverthe-
less, as will be described later in this review, recent advances
should allow a much more sophisticated and meaningful
approach to this topic.
Excitatory Transmission. Analogous to synapses in other brain
regions, excitatory synapses in the NAc can express several
different forms of synaptic plasticity, including NMDAR-depen-
dent LTD and LTP, endocannabinoid-dependent LTD (eCB
LTD), and a presynaptic form of mGluR-triggered LTD (for
reviews, see Thomas and Malenka, 2003; Surmeier et al.,
2007; Lu¨scher and Huber, 2010). Similar to the VTA, evidence
is accumulating that, in vivo, drugs of abuse can activate or
‘‘hijack’’ some of these synaptic plasticity mechanisms as well
as influence the subsequent generation of synaptic plasticity in
slices prepared from animals with a history of drug intake.
Assuming that plasticity at NAc excitatory synapses has evolved
to serve adaptive behavioral functions, drug-induced synaptic
adaptations will have important influences on subsequent
behaviors.
As was the case for modifications within the VTA, pharmaco-
logical and biochemical studies first suggested that alterations in
excitatory, glutamatergic synaptic function within the NAc may
be important for the behavioral adaptations elicited by adminis-
tration of drugs of abuse (Vanderschuren and Kalivas, 2000;
Wolf, 1998). Direct support for this hypothesis came from elec-
trophysiological studies that used the same strategy as the
ex vivo experiments performed in the VTA. Noncontingent
administration of cocaine for 5 days caused a decrease in the
AMPAR/NMDAR ratio at synapses on NAc MSNs when
measured 24 hr later or after a single challenge dose of cocaine
following a 10–14 day withdrawal period (Kourrich et al., 2007;
Thomas et al., 2001). This decrease was accompanied by
a reduction in the magnitude of NMDAR-dependent LTD. Pro-
longed cocaine self-administration also reduced excitatory
synaptic responses recorded extracellularly in the NAc shell
(Schramm-Sapyta et al., 2006) and was associated with an
inability to elicit LTD in both the core and the shell (Martin
et al., 2006). LTD in the NAc core could still not be elicited
even following 21 days of abstinence yet was present in NAc sli-
ces prepared from animals that self-administered food or
received cocaine passively in a yoked design (Martin et al.,
2006). These results suggest that some specific aspects of the
cocaine self-administration protocol result in a long-lasting
adaptation in NAc MSNs that impairs LTD.
A confusing aspect of the results summarized thus far is that
an extensive body of evidence suggests that activation, not inhi-
bition, of NAc MSNs by prefrontal cortical afferents is important
for the reinstatement of drug seeking (Knackstedt and Kalivas,
2009). Indeed, surface levels of AMPARs in the NAc are
increased for several weeks during withdrawal following
repeated noncontingent cocaine administration (Boudreau
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Figure 3. Drug-Evoked Synaptic Plasticity
in Excitatory Synapses onto Medium-Sized
Spiny Neurons in the NAc
The schematics are drawn from a postembedding
EMmicrograph of a drug-naivemouse (courtesy of
Rafael Lujan, Albacete, Spain). Note that these
neurons have prominent spines. In naive animals,
NMDARs and GluA2-containing AMPARs are
present. After several doses of cocaine (or a chal-
lenge dose that terminates withdrawal), some
AMPARs are endocytosed and the synapse
depressed. After weeks of withdrawal, GluA-lack-
ing AMPARs appear that lead to a potentiation of
this synapse.
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ratio recorded from NAc shell MSNs was increased 10–14 days
following 5 days of repetitive cocaine administration (Kourrich
et al., 2007). Importantly, in all these studies, a challenge dose
of cocaine was not administered 24 hr before the electrophysio-
logical recordings. A day after a challenge dose of cocaine,
terminating a protracted withdrawal period, both the surface
levels of AMPARs and the AMPAR/NMDAR ratio in NAc MSNs
are decreased (Boudreau et al., 2007; Kourrich et al., 2007;
Wolf and Ferrario, 2010; Bachtell and Self, 2008). Within
a week, the surface levels of AMPARs recovered and eventually
stabilized at an enhanced level.
An additional drug-induced synaptic adaptation in the NAc
occurs during protracted (6–7 weeks) withdrawal from cocaine
self-administration, a period that is associated with an increase
in cue-induced cocaine seeking (a model for craving) (Grimm
et al., 2001). While normally synapses on NAc MSNs contain
the AMPAR subunit GluA2, rendering AMPARs Ca-imperme-
able, 6 weeks following cessation of cocaine self-administration,
a proportion of synaptic AMPARs now lack GluA2, making them
Ca-permeable (Conrad et al., 2008). As discussed below, this
change in the stoichiometry of AMPARs has important behav-
ioral ramifications.
Another intriguing finding with potential functional importance
is that 1–2 days following repetitive noncontingent cocaine
administration, NAc shell MSNs express a relatively large
proportion of so-called silent synapses due to the insertion ofNeuron 69,NR2B-containing NMDARs (Huang et al.,
2009). Because silent synapses contain
NMDARs but no or very few AMPARs
(Malenka and Nicoll, 1997), they are ideal
substrates for LTP (Marie et al., 2005)
and thus may importantly contribute to
the increase in AMPAR surface expres-
sion and AMAPR/NMDAR ratios that
occur during prolonged withdrawal
periods. All of the findings reviewed thus
far can be incorporated into a relatively
simple model of the changes that occur
in excitatory synaptic strength during
different time periods of withdrawal/chal-
lenge injections from cocaine administra-
tion (Figure 3). As recently pointed out
(Russo et al., 2010), these correlate wellwith the cocaine-elicited structural changes in dendritic spines
on NAc MSNs and will be further discussed below.
PFC
Only a handful of studies report drug-evoked synaptic plasticity
in neurons of the PFC. Applying biochemical methods to PFC
tissue and isolating a synaptic membrane preparation, it was
proposed that GluA2 was endocytosed when cues previously
associated with heroin self-administration were presented to
a rat (Van den Oever et al., 2008). These findings were paralleled
by a decrease in the AMPAR/NMDAR ratio measured in acute
PFC slices, while self-administration of heroin alone did not
affect synaptic strength. Other studies focusing on withdrawal
from cocaine performed immunoblotting assays for several
synaptic proteins in the dorsal medial PFC and reported an
increased expression of NR2B at 14 days and of NR2A at
60 days of withdrawal (Ben-Shahar et al., 2009). Subcellular frac-
tionation techniques revealed a significant increase in the traf-
ficking of these receptors into the synaptosomal compartment
(Ghasemzadeh et al., 2009).
More recently, a study observed a gradual increase in the
expression of brain-derived neurotrophic factor (BDNF) in the
mPFC during acute withdrawal from repetitive cocaine exposure
in rats (Lu et al., 2010). This led to a downregulation of GABA-AR-
mediated transmission and a subsequent facilitation of activity-
induced long-term potentiation (LTP) of excitatory synapses on
layer V pyramidal neurons. Taken together, these studies
suggest that exposure to addictive drugs also causes glutamateFebruary 24, 2011 ª2011 Elsevier Inc. 655
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sive literature implicating the PFC in drug-related behavior, is
not surprising. In the future, direct characterizations of drug-
evoked synaptic plasticity in identified synapses will allow for
a better understanding of the circuit adaptations in the PFC in
response to addictive drugs.
Drug-Evoked Synaptic Plasticity and Neural Circuit
Adaptations
To understand the repercussion of drug-evoked synaptic plas-
ticity on the behavior of mesocorticolimbic DA system neural
circuitry, synaptic transmission must be studied in a cell-type-
specific manner on identified inputs. In other words, future
studies will have to resolve the origin of the synapses being
monitored (i.e., which afferents are being stimulated), the
detailed identity of the recorded neurons, and the targets to
which these neurons project. Approaches such as cell-type-
specific expression of fluorescent markers, retrograde labeling
of neurons using in vivo injection of retrobeads or viruses, and
expression of ChR2 or the inhibitory halorhodopsin in restricted
sets of afferents by vector delivery into upstream brain areas will
have to be applied in combination so that control of identified
sets of synapses can be achieved (Witten et al., 2010; Stuber,
2010; Wall et al., 2010; Haubensak et al., 2010; Ciocchi et al.,
2010).
An example of the types of studies that will advance our under-
standing of the neural circuit adaptations that underlie addiction
comes from experiments using BAC transgenic mice in which
specific subpopulations of cells can be labeled with fluorescent
markers (Gong et al., 2003). Asmentioned above, NAcMSNs are
not homogeneous but, like MSNs in the dorsal striatum, can be
divided into two major subpopulations (Kreitzer and Malenka,
2008; Sesack and Grace, 2010; Gertler et al., 2008). Direct
pathway MSNs express D1 DA receptors and project directly
to midbrain DA areas, whereas indirect pathway MSNs express
D2 DA receptors and project to the ventral pallidum. In the dorsal
striatum, there is growing evidence that these two subpopula-
tions of MSNs exhibit different physiological and synaptic prop-
erties, including different forms of synaptic plasticity (Kreitzer
and Malenka, 2008; Shen et al., 2008). Indeed, independent
manipulation of the activity of direct and indirect pathway
MSNs in the dorsal striatum directly demonstrated that they
participate in distinct circuits that mediate dramatically different
behaviors (Hikida et al., 2010; Kravitz et al., 2010).
Very little is known about differences in the properties of NAc
indirect and direct pathway MSNs. Using targeted recordings
from BAC transgenic mice that express fluorescent proteins in
one or the other MSN population (Gong et al., 2003; Shuen
et al., 2008), it was recently reported that the basal properties
of indirect and direct pathway MSNs in the NAc core differ in
a manner quite similar to the differences observed in dorsal stria-
tal MSNs (Kreitzer and Malenka, 2008; Grueter et al., 2010). D2
DA receptor-expressing indirect pathway MSNs are more excit-
able, and the excitatory synapses on these cells exhibit a higher
probability of release. Furthermore, while NMDAR-dependent
LTD can be generated to the same degree in both subtypes of
MSNs, as in the dorsal striatum, eCB LTD is generated much
more robustly in indirect pathway NAc MSNs (Kreitzer and656 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.Malenka, 2007; Grueter et al., 2010). This was surprising, given
that eCB LTD in the NAc had been reported previously in slices
from wild-type mice in which it was not possible to make tar-
geted recordings (Robbe et al., 2002). However, the techniques
used in this previous report, extracellular field recordings, do not
allow the source of the postsynaptic responses to be deter-
mined. An additional surprising finding was that the eCB LTD
in NAc indirect pathway MSNs was not completely blocked by
a CB1 receptor antagonist. This observation led to an extensive
set of experiments demonstrating that, in addition to standard
eCB LTD, NAc indirect pathway MSNs express a novel form of
LTD triggered by activation of postsynaptic TRPV1 channels
(Grueter et al., 2010). A very similar form of postsynaptic
TRPV1-triggered LTD was found in medial perforant path
synapses on dentate gyrus granule cells (Cha´vez et al., 2010),
suggesting that this may be a ubiquitous, albeit highly input-
specific, form of synaptic plasticity.
The potential importance of the restriction of these forms of
LTD to one MSN subtype is that in contrast to NMDAR-depen-
dent LTD, the eCB LTD observed in the NAc is dramatically
impaired 24 hr following only a single dose of either cocaine or
9-THC (Fourgeaud et al., 2004; Mato et al., 2004). Similarly, the
eCB- and TRPV1-dependent LTD in indirect pathway NAc
MSNs was absent 24 hr after administration of a single dose of
cocaine (Grueter et al., 2010). The inhibition of these forms of
LTD by cocaine is consistent with the suggestion that the
cocaine treatment impairs postsynaptic mGluR signaling, which
is required for the generation of eCBs in NAc MSNs (Fourgeaud
et al., 2004). The behavioral function of these forms of LTD and
their block by cocaine is unknown. Interestingly, although basal
locomotor activity was normal in knockout mice lacking TRPV1,
these mice exhibited an enhanced locomotor response to
cocaine that was maintained as behavioral sensitization devel-
oped with repeated daily administration of cocaine (Grueter
et al., 2010). Assuming that the absence of TRPV1 specifically
in NAc indirect pathwayMSNswas responsible for the enhanced
cocaine-induced locomotor activity, the LTD triggered by TRPV1
may function as a brake on cocaine-elicited locomotor activity.
This role is opposite to that proposed for NMDAR-dependent
LTD. However, since the TRPV1-dependent LTD is restricted
to indirect pathway MSNs while NMDAR-dependent LTD occurs
in both subtypes of MSNs, it is not unexpected that these forms
of synaptic plasticity may have different behavioral roles.
The results summarized thus far emphasize the importance of
defining the cell type in which drug-induced adaptations have
occurred. As mentioned above, of equal importance will be
defining the source of the synapses being studied. Currently,
using ex vivo approaches that involve preparing acute brain slices
from animals that have had drug experience, it is very difficult to
know definitively which sets of inputs are being activated. For
the NAc, these arise primarily from the PFC, subiculum, or amyg-
dala. Furthermore, with standard techniques, it is impossible to
prevent the activation of GABAergic, dopaminergic, or other
modulatory inputs within the slice. The potential importance of
distinguishing the different NAc afferents is exemplified by
in vivo experiments during which it is possible to activate specific
sets of inputs independently. For example, at hippocampal-NAc
synapses, LTP recorded using extracellular field potentials was
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tingent cocaine administration, whereas LTP at prefrontal-NAc
synapses was unaffected (Goto and Grace, 2005). On the other
hand, in acute slices prepared 2 weeks after repetitive cocaine
administration, LTP, also assayed using field potentials and
generated by presumptive prefrontal-NAc synapses, was
modestly enhanced (Yao et al., 2004). Finally, during withdrawal
from cocaine self-administration, both LTP and LTD at
prefrontal-NAc synapses in vivo were impaired (Moussawi
et al., 2009). The difference in these results may reflect that
different sets of inputs were in fact stimulated as well as the
differences in the drug administration protocols. A significant
limitation of using in vivo preparations is the technical difficulty
of recording synaptic responses from individual cells. Instead,
extracellular field potentials are normally recorded, changes in
which are difficult to interpret since the potentials are generated
both by synaptic responses and voltage-dependent conduc-
tances. A further limitation of in vivo extracellular recordings is
the difficulty in performing assays of basal synaptic properties
in amanner that permits cross-preparation comparisons. Ideally,
it would be valuable to combine the advantages of both in vivo
and ex vivo approaches while minimizing their limitations. An
obvious approach to accomplish this in the service of elucidating
the modifications caused by drugs of abuse at known sets of
synapses will be to express ChR2 in the specific brain regions
that project to NAc in BAC transgenic mice and then prepare
acute slices from these animals following in vivo drug exposure.
Many labs worldwide, including the authors’ labs, are taking this
approach with good success.
It will also be important to understand how the different forms
of drug-evoked plasticity in the mesocorticolimbic system relate
to each other. Anatomical analysis in rodents and nonhuman
primates suggests that the midbrain and striatal components
of the mesocorticolimbic DA system are connected in a spiraling
manner (Haber et al., 2000; Ikemoto, 2007). DA neurons of the
medial VTA project to the medial shell, from which MSNs
back-project to more lateral parts of the VTA. This back-projec-
tion most likely involves a relay via an interneuron in the VTA
(Maeda and Mogenson, 1981; Xia et al., 2010). These DA
neurons then project to the NAc core, from where MSNs back-
project to even more lateral VTA, and after several additional
loops, the circuit reaches the substantia nigra (SNc), which
projects to the dorsal striatum. The ascending projections are
generally dopaminergic, along with a glutamatergic component
for a subset of neurons that corelease both transmitters (Dobi
et al., 2010). NAc MSNs that send GABAergic projections to
the VTA are likely to be direct pathway or D1-expressing
neurons, but most MSNs reach DA neurons only via inhibitory
interneurons located in the VTA. Enhanced activity of MSN
neurons may therefore actually excite DA neurons. An appealing
hypothesis is that drug-evoked synaptic plasticity reinforces the
connectivity within the spiral, which would lead to the recruit-
ment of more and more dorsal projections as drug use becomes
chronic. In line with this idea are the observations that a single
injection of cocaine triggers drug-evoked synaptic plasticity in
VTA DA neurons that project to the medial NAc shell, while
several injections are required to downregulate inhibitory trans-
mission onto DA neurons.One study has attempted to directly link early changes
induced by cocaine in the VTA (i.e., increased AMPAR/NMDAR
ratios and appearance of inward rectification in AMPAR EPSCs)
to later cocaine-evoked plasticity in the NAc (i.e., decreased
AMPAR/NMDAR ratios followed by inward rectification after pro-
longedwithdrawal) (Mameli et al., 2009). Consistent with a causal
link, abolishing the drug-evoked synaptic plasticity only in the
VTA by inducible deletion of the obligatory NMDAR subunit
NR1 only in DA cells (see above) prevented drug-evoked
synaptic changes in the NAc. Furthermore, manipulating the
persistence of the cocaine-evoked plasticity in the VTA
controlled synaptic plasticity in the NAc. These results are remi-
niscent of earlier findings, suggesting that the psychostimulant-
induced behavioral sensitization requires the VTA but that its
expression is independent of the VTA and requires modifications
within the NAc (Wolf, 1998). They also support the idea that there
is a hierarchical relationship between these forms of drug-
evoked synaptic plasticity in the early phases of the spiral.
Future studies will have to identify the ‘‘master signals’’ that
control this hierarchical organization between VTA and NAc
and test whether similar mechanisms control the circuit remod-
eling in later stages of the spiral. Will chronic drug exposure
eventually affect transmission in the SNc and the dorsal stria-
tum? One study implicated the recruitment of these dorsal parts
of the DA system in cocaine-seeking habits by demonstrating
that the surgical disconnection of the spiral via a lesion of the
NAc core blocked the development of cocaine seeking in rats
(Belin and Everitt, 2008). Thus, the spiral appears to be engaged
sequentially during the development of addiction. Drug-evoked
synaptic plasticity in various parts of the mesocorticolimbic
systemmay constitute the underlying cellular correlate, confirm-
ing the hypothesis that ‘‘staged neuroplasticity’’ underlies the
disease (Kalivas and O’Brien, 2008). A model of the mesocorti-
colimbic circuitry that is subject to drug-evoked synaptic plas-
ticity is emerging (Figure 4 and Table 1). While this model is
based on a decade’s work, it is apparent that many questions
regarding the anatomical connections and precise cellular
mechanisms remain unanswered.
Beyond Synaptic Adaptations
Of course, synaptic adaptations are not the only mechanisms by
which drugs of abuse can modify mesocorticolimbic DA system
circuitry to cause long-lasting behavioral changes. In vivo expo-
sure to addictive substances activate complex intracellular
signaling cascades including transcription factors, cause
changes in intrinsic membrane excitability, affect dendrite and
spine structure, and influence the levels of extracellular gluta-
mate via impairments in cysteine-glutamate exchange. These
additional drug-induced adaptations have been the subject of
several recent reviews, which attempt to integrate all of these
findings into a coherent view of the neural circuit adaptations
that mediate addiction (Russo et al., 2010; Kalivas et al., 2009;
Wolf, 2010).
Linking Synaptic Plasticity and Behavior
The toughest challenge for all forms of synaptic plasticity is the
demonstration of a causal link between a specific synapticmodi-
fication and a specific behavior. Indeed, the specific behavioral
role of the original form of long-lasting synaptic plasticity,Neuron 69, February 24, 2011 ª2011 Elsevier Inc. 657
PFC
VTA
NAc
Brainstem
AMPA/NMDA ratio goes up
AMPA/NMDA ratio goes down
(several doses or challenge
after short withdrawal)
prolonged withdrawal)
LTP (GABA) is blocked (one dose)
GABAA transmission reduced (several
doses)
AMPA/NMDA ratio goes down
when drug-associated cue
is presented
AMPA/NMDA ratio goes up
(salient, but aversive stimulus)
Figure 4. Emerging Model of Mesolimbic Circuit Known to Be Affected by Drug-Evoked Synaptic Plasticity
For simplicity, several projections have been omitted to highlight the synapses that undergo drug-evoked adaptations. For further explanation, see text. Dopa-
mine neurons, red; GABA neurons, green; glutamate neurons, blue.
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ocally demonstrated. Space constraints prevent us from review-
ing all the behavioral literature implicating drug-evoked synaptic
plasticity in addiction-related behaviors. Instead, we will focus
on studies that have used ex vivo approaches to correlate
drug-elicited behavioral changes with mechanistic investiga-
tions of the underlying synaptic plasticity. The behavioral models
mimicking core components of drug addiction that have been
studied most extensively in this context are self-administration,
locomotor sensitization, conditioned place preference (CPP),
drug-evoked relapse, cue-induced cocaine seeking, and incu-
bation of craving.
Given that the VTA has been implicated in both behavioral
sensitization and CPP, several studies have attempted to link
these drug-induced behavioral changes with drug-evoked plas-
ticity of excitatory transmission in the VTA. Initial findings indeed
seemed to confirm the link; pharmacological inhibition of
NMDARs in the VTA blocks the drug-evoked synaptic plasticity
and behavioral sensitization (Dunn et al., 2005; Kalivas and Ales-
datter, 1993; Vezina andQueen, 2000) as well as CPP (Harris and
Aston-Jones, 2003; Harris et al., 2004). Furthermore, the expres-
sion via viral vectors of the AMPAR subunit GluA1 in the VTA led
to behavioral sensitization in animals that had never been658 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.exposed to cocaine (Carlezon and Nestler, 2002). Surprisingly,
however, behavioral sensitization to cocaine could still be eli-
cited in GluA1/ mice even though the drug-evoked increase
in the AMPAR/NMDAR ratio was abolished (Dong et al., 2004).
The GluA1/ mice did exhibit impaired CPP, which suggested
that the drug-evoked plasticity of excitatory synaptic transmis-
sion in VTA DA neurons, although not required for behavioral
sensitization per se, may contribute to the attribution of incentive
value to drug-associated cues.
More selective genetic manipulations, however, call this inter-
pretation into question. Specifically, conditionally deleting the
NMDAR subunit NR1 selectively in DA neurons of adult mice
caused a loss of NMDAR-EPSCs as well as the cocaine-evoked
synaptic plasticity, yet behavioral sensitization and CPP were
still normal (Engblom et al., 2008). A behavioral repercussion of
this genetic manipulation became apparent only during the with-
drawal period following drug self-administration, a time period
during which the normal reinstatement of self-administration
triggered by a priming dose of cocaine was abolished, or when
cue-induced cocaine seeking after more than a month of with-
drawal was significantly reduced (Mameli et al., 2009). The post-
natal, rather than constitutive, deletion of NR1 from DA neurons
may explain an apparent difference with another study in which
Table 1. Key Forms of Drug-Evoked Synaptic Plasticity
Brain
Area
Postsynaptic
Cell Transmission
Drug Treatment
Required Induction Expression
Examples
in the Literaturea
VTA DA neurons Excitatory One injection of
cocaine and other
addictive drugs,
as well as acute
stress
Activation of NMDAR on
DA neurons and D1-like
receptors, presumably
on excitatory afferents
Increase of AMPAR/
NMDAR and
rectification: insertion
of GluA2-lacking
AMPARs and decrease
of NMDAR function
Ungless et al., 2001; Saal
et al., 2003; Bellone and
Lu¨scher, 2006; Mameli
et al., 2011
DA neurons Inhibitory One injection of
morphine, cocaine,
or nicotine or
accute stress
Nitric oxide Decreased GABA
release
Nugent et al., 2007; 2009
DA neurons Excitatory Only present in
slices of mice that
have received
cocaine injection
mGluR1 Removal of
GluA2-lacking
AMPARs
Bellone and Lu¨scher,
2006; Mameli et al., 2007
DA neurons Inhibitory Five daily injections
of cocaine
BDNF Decrease of the number
of GABAA receptors
Liu et al., 2005
NAc MSN Excitatory Weeks after several
days of cocaine
self-administration
(incubation of craving)
n/a GluA2-lacking AMPARs Conrad et al., 2008
MSN Excitatory Seven injections of
cocaine, followed by
1 week of withdrawal
and one challenge
injection
Decrease of AMPAR/
NMDAR ratio
NMDAR-dependent LTD,
silent synapses
Thomas et al., 2001
MSN Excitatory Five daily injections,
followed by 10–14
days of withdrawal
n/a Increase of AMPAR/
NMDAR ratio
Kourrich et al., 2007
MSN Excitatory Single or multiple
injections of cocaine
inhibit mGluR5 LTD
Post-mGluR5 Presynaptic via
endocannabinoids
Moussawi et al., 2009
MSN
(D2-expressing)
Excitatory Blocked 24 hr after one
injection of cocaine
TrpV1 channel Postsynaptic Grueter et al., 2010
Medial
PFC
Pyramidal
neurons
Excitatory 3-week withdrawal and
then cue presentations
n/a Cue-induced decrease
of AMPAR/NMDAR
Van den Oever et al.,
2008
Layer V
pyramidal
neurons
Inhibitory/
Excitatory
Seven daily injections,
followed by 5–17 days
of withdrawal
BDNF-dependent
decrease of GABAA
transmission
Facilitated LTP Lu et al., 2010
a The cited literature here is not exhaustive. We apologize for not being able to cite all the work because of space constraints.
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neurons exhibited impaired CPP (Zweifel et al., 2008). In these
mice, the absence of NMDARs during development led to an
increase/decrease in AMPAR-EPSCs, presumably due to
a form of synaptic scaling (Adesnik et al., 2008). Interestingly,
in the same DATCre-NR1 mouse, behavioral sensitization was
abolished when the NMDAR antagonist AP5 was directly applied
into the VTA, implicating NMDARs on non-DA neurons in this
behavior (Luo et al., 2010).
The behavioral relevance of drug-evoked synaptic plasticity in
the NAc has been examined in several studies. To test whether
LTD in the NAc was required for amphetamine-induced behav-
ioral sensitization, a membrane-permeable peptide that
prevents endocytosis of AMPARs and thus NMDAR-dependent
LTDwas infused into the NAc of sensitized rats immediately priorto a challenge dose of amphetamine (Brebner et al., 2005). This
manipulation prevented the increase in locomotor activity nor-
mally elicited by amphetamine, suggesting that drug-elicited
LTD in the NAc is required for the expression of behavioral sensi-
tization. More recently, the behavioral importance of the impair-
ment of NMDAR-dependent LTD in the NAc caused by cocaine
has been addressed by taking advantage of the observation that
following prolonged cocaine self-administration, only a modest
proportion of rats develop behaviors analogous to human
addicts (Deroche-Gamonet et al., 2004; Kasanetz et al., 2010).
Although approximately 2 weeks following the cessation of
cocaine self-administration, LTD was impaired in all animals,
the ability to generate LTD slowly recovered in ‘‘nonaddicted’’
animals. In contrast, ‘‘addicted’’ animals expressed persistently
impaired LTD (Kasanetz et al., 2010). If LTD in the NAc is indeedNeuron 69, February 24, 2011 ª2011 Elsevier Inc. 659
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lasting impairment may contribute to the inflexible, compulsive
behaviors that are a hallmark of addiction.
Another study presented strong evidence that synaptic adap-
tations within the NAc are important for cue-induced reinstate-
ment of drug self-administration. Withdrawal after prolonged
cocaine self-administration is associated with a so-called incu-
bation of craving (Grimm et al., 2001). Specifically, as time
passes during the withdrawal period, the presentation of a cue
previously associated with the availability of a drug leads to
increasing efforts (i.e., number of lever presses) to obtain the
drug. Over approximately this same time period, the initial
depression of excitatory transmission in the NAc reverses into
a potentiation and the appearance of calcium-permeable
AMPARs (see above). The behavioral importance of this change
in the stoichiometry of AMPAs was directly tested by infusing
into the NAc a compound that blocks GluA2-lacking AMPARs
(Conrad et al., 2008). This manipulation prevented the enhanced
cue-elicited drug seeking that normally occurs 6–7 weeks after
withdrawal from cocaine self-administration. Importantly,
infusing this compound into the NAc had no effect on cue-
elicited drug seeking the first day of withdrawal nor on sucrose
self-administration. Because GluA2-lacking AMPARs have
a higher conductance than GluA2-containing AMPARs, and
this withdrawal period is associated with an increase in the
AMPAR/NMDAR ratio, these findings are consistent with
a general increase in excitatory synaptic strength in NAc MSNs
during prolonged withdrawal from either self-administered or
noncontingent-administered cocaine (Russo et al., 2010; Kalivas
et al., 2009; Wolf, 2010).
Although synaptic adaptations were not examined, a study
worth mentioning directly tested the behavioral roles of NAc indi-
rect and direct pathway MSNs (Lobo et al., 2010). Optogenetic
activation of D1 receptor-expressing direct pathway NAc
MSNs dramatically enhanced the rewarding effects of
a threshold dose of cocaine in a CPP protocol, whereas activa-
tion of D2 receptor-expressing indirect pathway NAc MSNs
dramatically attenuated cocaine reward. Othermolecular manip-
ulations of direct versus indirect pathway MSNs in the striatum
also support the hypothesis that the specific circuits in which
these two subpopulations of MSNs participate have profoundly
different behavioral roles in addiction-related behaviors (Hikida
et al., 2010; Bateup et al., 2010).
Conclusions
We have reviewed a growing body of evidence indicating that
drug-evoked synaptic plasticity in the mesocorticolimbic DA
system is common to all addictive drugs and is rooted in their
common pharmacological effect of increasing DA in specific
target structures. An appealing hypothesis therefore posits that
drug-evoked changes in the VTA may constitute an initial
permissive step for changes in the NAc and PFC, which then
mediate many of the core behavioral changes that define addic-
tion. The well-documented effects of the different classes of
addictive drugs on other brain regions may in turn mediate
specific symptoms that make the addiction to a specific drug
unique. This model proposes a hierarchical system of several
forms of nested drug-evoked plasticity, which in part underlie660 Neuron 69, February 24, 2011 ª2011 Elsevier Inc.the circuit reorganization that eventually leads to a transition
from thoughtful, balanced decisions to the automatic, compul-
sive decisions that are a hallmark of addiction. Future studies
will have to work out the functional connectivity and identify
the signals orchestrating the various forms of drug-evoked plas-
ticity. Of equal importance will be determining the basis for the
individual vulnerability to develop addiction. Only with a more
sophisticated understanding of these topics will mechanistically
solid and clinically efficient treatments become available.
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